Zhimeng Biopharma
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$99.8M
Momentum Score
25 /100
Company Overview
Zhimeng Biopharma is a biopharmaceutical company focused on developing innovative therapies aimed at all stages of the hepatitis B virus, including nucleocapsid inhibitors, RNA destabilizers, and immunomodulators to enhance treatment options for healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhimeng Biopharma Comps
Public and private peers based on sector, stage, and business model.
Zhimeng Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A | Nov 6, 2020 | ||||
| Pre Seed | Nov 11, 2019 |
Zhimeng Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series A |
| Trinity Innovation Fund | Series A |
| Lake Capital | Pre Seed |
| Oceanpine Healthcare Fund | Series A |
| State Development and Investment Group Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Monthly visitors increased 112% MoM.
Zhimeng Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zhimeng Biopharma's valuation, stock price, and market status.
